EZH2 inhibition confers PIK3CA-driven lung tumors enhanced sensitivity to PI3K inhibition. Chen F, Liu J, Song X, DuCote TJ, et al. Cancer Lett 2022;524:151-160.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen F, Liu J, Song X, DuCote TJ, et al. EZH2 inhibition confers PIK3CA-driven lung tumors enhanced sensitivity to PI3K inhibition. Cancer Lett 2022;524:151-160.
PMID: 34655667